These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9372439)

  • 1. Glycopeptide-resistant enterococci in Northern Ireland: first reported outbreak.
    Rizkalla EA; Moore JE; Marshall SA; Murphy PG
    J Antimicrob Chemother; 1997 Oct; 40(4):607-8. PubMed ID: 9372439
    [No Abstract]   [Full Text] [Related]  

  • 2. First emergence of glycopeptide-resistant enterococci infections in Greece.
    Routsi C; Platsouka E; Armaganidis A; Paniara O; Roussos C
    Scand J Infect Dis; 2001; 33(1):80. PubMed ID: 11234989
    [No Abstract]   [Full Text] [Related]  

  • 3. First outbreak of linezolid-resistant vancomycin-resistant Enterococcus faecium in an Irish hospital, February to September 2014.
    O'Driscoll C; Murphy V; Doyle O; Wrenn C; Flynn A; O'Flaherty N; Fenelon LE; Schaffer K; FitzGerald SF
    J Hosp Infect; 2015 Dec; 91(4):367-70. PubMed ID: 26520594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of high-throughput sequencing to investigate an outbreak of glycopeptide-resistant Enterococcus faecium with a novel quinupristin-dalfopristin resistance mechanism.
    Shaw TD; Fairley DJ; Schneiders T; Pathiraja M; Hill RLR; Werner G; Elborn JS; McMullan R
    Eur J Clin Microbiol Infect Dis; 2018 May; 37(5):959-967. PubMed ID: 29478197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First outbreak of colonization by linezolid- and glycopeptide-resistant Enterococcus faecium harbouring the cfr gene in a UK nephrology unit.
    Inkster T; Coia J; Meunier D; Doumith M; Martin K; Pike R; Imrie L; Kane H; Hay M; Wiuff C; Wilson J; Deighan C; Hopkins KL; Woodford N; Hill R
    J Hosp Infect; 2017 Dec; 97(4):397-402. PubMed ID: 28698020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of carriage of glycopeptide-resistant enterococci by at-risk hospitalised patients in Malta.
    Decelis S; Borg MA; Cuschieri P
    Clin Microbiol Infect; 2004 Sep; 10(9):861-2. PubMed ID: 15355423
    [No Abstract]   [Full Text] [Related]  

  • 7. Vancomycin resistant enterococci in hospitals in the United Kingdom--1995.
    Commun Dis Rep CDR Wkly; 1996 Aug; 6(31):267. PubMed ID: 8791882
    [No Abstract]   [Full Text] [Related]  

  • 8. First vancomycin-resistant Enterococcus faecium outbreak reported in Hungary.
    Böröcz K; Szilágyi E; Kurcz A; Libisch B; Glatz K; Gacs M
    Euro Surveill; 2005 Jan; 10(1):E050127.1. PubMed ID: 16556951
    [No Abstract]   [Full Text] [Related]  

  • 9. Glycopeptide-resistant enterococci: a decade of experience.
    Woodford N
    J Med Microbiol; 1998 Oct; 47(10):849-62. PubMed ID: 9788808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Implementation of vanA and vanB genes by PCR technique research interest in system (Xpert vanA/vanB CepheidR) closed in a laboratory of microbiology in managing an outbreak to Enterococcus faecium resistant glycopeptide (EfRG)].
    Dekeyser S; Beclin E; Descamps D
    Pathol Biol (Paris); 2011 Apr; 59(2):73-8. PubMed ID: 20828941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycopeptide-resistant enterococci: deciphering virulence, resistance and epidemicity.
    Willems RJ; Bonten MJ
    Curr Opin Infect Dis; 2007 Aug; 20(4):384-90. PubMed ID: 17609597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of tigecycline, daptomycin, linezolid and quinupristin/dalfopristin against glycopeptide-resistant Enterococcus faecium.
    Abb J
    Int J Antimicrob Agents; 2007 Mar; 29(3):358-60. PubMed ID: 17229553
    [No Abstract]   [Full Text] [Related]  

  • 13. Characteristics of Vancomycin-Resistant Enterococcus Strains in the West Balkans: A First Report.
    Jakovac S; Bojić EF; Ibrišimović MA; Tutiš B; Ostojić M; Hukić M
    Microb Drug Resist; 2017 Jan; 23(1):122-126. PubMed ID: 27351410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glycopeptide-resistant Enterococcus outbreak in an ICU with simultaneous circulation of two different clones].
    Delamare C; Lameloise V; Lozniewski A; Perrin M; Baudin C; Sellies J; Dumay M; Bemer M;
    Pathol Biol (Paris); 2008; 56(7-8):454-60. PubMed ID: 18835105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infection caused by glycopeptide resistant pathogens].
    Korn SJ; Stille W
    Internist (Berl); 2000 Dec; 41(12):1344-52. PubMed ID: 11189069
    [No Abstract]   [Full Text] [Related]  

  • 16. Report of a meeting on the epidemiology and control of glycopeptide-resistant enterococci.
    Chadwick PR; Chadwick CD; Oppenheim BA
    J Hosp Infect; 1996 Jun; 33(2):83-92. PubMed ID: 8808742
    [No Abstract]   [Full Text] [Related]  

  • 17. Vancomycin-resistant enterococci on a renal ward in an Ontario hospital.
    Lior L; Litt M; Hockin J; Kennedy C; Jolley BA; Garcia M; Gillis G; Humar A; Campbell I; Brunton J; Dedier H; Conly J
    Can Commun Dis Rep; 1996 Aug; 22(15):125-8. PubMed ID: 8791860
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiology and control of multiresistant enterococci.
    Leclercq R
    Drugs; 1996; 52 Suppl 2():47-9. PubMed ID: 8869836
    [No Abstract]   [Full Text] [Related]  

  • 19. Vancomycin resistant enterococci in hospitals in the United Kingdom.
    Commun Dis Rep CDR Wkly; 1995 Dec; 5(50):281, 284. PubMed ID: 8589789
    [No Abstract]   [Full Text] [Related]  

  • 20. [Glycopeptide resistant enterococci. Occurrence, distribution, resistance transmission, significance].
    Klare I; Witte W
    Wien Klin Wochenschr; 1997 May; 109(9):293-300. PubMed ID: 9265387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.